Which MONA LISA® IUD to recommend?
| Product | MONA LISA® 10 (CuT 380A QL) | MONA LISA® 5 (NT Cu380) | MONA LISA® 5 mini (NT Cu380) | MONA LISA® N (ST Cu300) |
|---|---|---|---|---|
| Effective contraception (years) | 10 | 5 | 5 | 3 |
| Surface Area of Copper | 380 mm2 | 380 mm2 | 380 mm2 | 300 mm2 |
| Dimensions | Length: 35.85 mm ± 0.25 mm Width: 31.85 mm ± 0.25 mm | Length: 31.9 mm ± 0.2 mm Width: 31.8 mm ± 0.2 mm | Length: 30.0 mm ± 0.2 mm Width: 24.0 mm ± 0.2 mm | Length: 29.1 mm ± 0.2 mm Width: 23.0 mm ± 0.1 mm |
| Uterine cavity depth | Designed for women with uterine cavity depth between 6.5-9 cm | Designed for women with uterine cavity depth between 6.5-9 cm | Designed for women with uterine cavity depth less than 7 cm | Designed for women with uterine cavity depth less than 6 cm |
| Specifications | Preloaded applicator | Traditional 2 step technique | Traditional 2 step technique | Push technique |
| Ideal for | Women who have completed their family | Parous women spacing their children | Nulliparous women and/or parous women with short uterus | Nulliparous women |
  | | | |
For more information, refer to the articles below.
The Cu safe 300 IUD, a new concept in intrauterine contraception: first-year results of a large study follow-up of 1017 acceptors. Kurz & Meier-Oehlke, Adv Contracept 1991;7(2-3):291-300.
(https://www.ncbi.nlm.nih.gov/pubmed/1950725)
Effectiveness, safety and acceptability of a copper intrauterine device (Cu Safe 300) in type 1 diabetic women. Kimmerle et al., Diabetes Care 1993;16(9):1227-1230.
(https://www.ncbi.nlm.nih.gov/pubmed/8404424)
A randomized comparative study of the TCu380A and Cu-safe 300 IUDs. Van Kets et al., Adv Contracept 1995;11(2):123-129.
(https://www.ncbi.nlm.nih.gov/pubmed/7491853)
Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C. UNDP et al., Contraception 1997;56(6): 341-352.
(https://www.ncbi.nlm.nih.gov/pubmed/9494767)
Comparison of the performances of TCu380A and TCu380S IUDs up to five years. L. Bahamondes et al., Adv Contracept 1999;15(4):275-281.
(https://www.ncbi.nlm.nih.gov/pubmed/11145369)
Five-year clinical experiences with Nova T380 copper IUD. Batar et al., Contraception 2002; 66(5):309-314.
(https://www.ncbi.nlm.nih.gov/pubmed/12443960)
Clinical performance of the Nova T380 intrauterine device in routine use by the UK family planning and reproductive health research network: 5 year report. Cox et al., J Fam Plann Reprod Health Care 2002;28(2):69-72.
(https://www.ncbi.nlm.nih.gov/pubmed/12396775)
A randomized trial on the clinical performance of Nova T380 and Gyne T380 Slimline copper IUDs, Haugan et al., Contraception 2007;75(3):171-176.
(https://www.ncbi.nlm.nih.gov/pubmed/17303485)
Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. Wu et al., BJOG 2010;117(10): 1205-1210
(https://www.ncbi.nlm.nih.gov/pubmed/20618314)